Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**echinops cephalotes manna** is a natural plant-derived exudate or extract preparation obtained from *Echinops cephalotes*. Based on the cited preclinical publication, it has been investigated in a mouse model of scopolamine-induced cognitive impairment, where *Echinops cephalotes* extracts and manna were studied for potential memory-enhancing and anti-Alzheimer activity. The reported pharmacology is not fully defined at the level of a single purified active constituent, but the source suggests anti-cholinesterase and butyrylcholinesterase inhibitory activity as the main proposed mechanism underlying potential cognitive benefit. There is no evidence from the provided context that this is an approved pharmaceutical product, branded medicine, or clinically developed single-molecule drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on echinops cephalotes manna.